Close Menu

NEW YORK ─Todos Medical said Tuesday that it has entered into a cross-distribution agreement with L1 Systems, a subsidiary of Omer, Israel-based Medigus, for the distribution of COVID-19 related products.

Under the agreement, L1 will have non-exclusive distribution rights to Todos' testing products, including RNA extraction equipment, RNA extraction reagents, qPCR reagents, digital PCR reagents, and SARS-CoV-2 rapid point-of-care antibody test kits.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.